share_log
Reuters ·  May 7 08:00
Sagimet Announces Oral Presentation of Data From the Phase 2B Fascinate-2 Study of Denifanstat in Mash at Easl International Liver Congress 2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment